Diasome is Trying to “Fix Insulin,” Then Hit Market
Diasome Pharmaceuticals enters a 200 person clinical trial to test an insulin additive designed to help diabetes patients gain more control over their blood sugar level.
Diasome Pharmaceuticals enters a 200 person clinical trial to test an insulin additive designed to help diabetes patients gain more control over their blood sugar level.